Suppr超能文献

《中国慢性疼痛治疗离子通道药物专家共识》

Expert Consensus on Ion Channel Drugs for Chronic Pain Treatment in China.

作者信息

Ma Ke, Cheng Zhixiang, Jiang Hao, Lin Zhangya, Liu Chuansheng, Liu Xianguo, Lu Lijuan, Lu Yan, Tao Wei, Wang Suoliang, Yang Xiaoqiu, Yi Qishan, Zhang Xiaomei, Zhang Ying, Liu Yanqing

机构信息

Department of Algology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.

Department of Algology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.

出版信息

J Pain Res. 2024 Mar 8;17:953-963. doi: 10.2147/JPR.S445171. eCollection 2024.

Abstract

Ion channel drugs have been increasing used for chronic pain management with progress in the development of selective calcium channel modulators. Although ion channel drugs have been proven safe and effective in clinical practice, uncertainty remains regarding its use to treat chronic pain. To standardize the clinical practice of ion channel drug for the treatment of chronic pain, the National Health Commission Capacity Building and Continuing Education Center for Pain Diagnosis and Treatment Special Ability Training Project established an expert group to form an expert consensus on the use of ion channel drugs for the treatment of chronic pain after repeated discussions on existing medical evidence combined with the well clinical experience of experts. The consensus provided information on the mechanism of action of ion channel drugs and their recommendations, caution use, contraindications, and precautions for their use in special populations to support doctors in their clinical decision-making.

摘要

随着选择性钙通道调节剂的发展,离子通道药物在慢性疼痛管理中的应用日益增加。尽管离子通道药物在临床实践中已被证明安全有效,但在其用于治疗慢性疼痛方面仍存在不确定性。为规范离子通道药物治疗慢性疼痛的临床实践,国家卫生健康委能力建设和继续教育中心疼痛诊疗专项能力培训项目成立了专家组,在结合专家丰富临床经验对现有医学证据进行反复讨论后,就离子通道药物治疗慢性疼痛的使用形成专家共识。该共识提供了离子通道药物的作用机制信息及其推荐意见、谨慎使用情况、禁忌证以及在特殊人群中使用的注意事项,以支持医生进行临床决策。

相似文献

1
Expert Consensus on Ion Channel Drugs for Chronic Pain Treatment in China.
J Pain Res. 2024 Mar 8;17:953-963. doi: 10.2147/JPR.S445171. eCollection 2024.
2
Expert consensus of the Chinese Association for the Study of Pain on ion channel drugs for neuropathic pain.
World J Clin Cases. 2021 Mar 26;9(9):2100-2109. doi: 10.12998/wjcc.v9.i9.2100.
3
[Chinese guidelines for the treatment of chronic pain disorders with non-opioid analgesics].
Zhonghua Yi Xue Za Zhi. 2023 Oct 24;103(39):3088-3102. doi: 10.3760/cma.j.cn112137-20230529-00876.
4
Ion channel blockers for the treatment of neuropathic pain.
Future Med Chem. 2010 May;2(5):803-42. doi: 10.4155/fmc.10.19.
5
Voltage gated sodium and calcium channel blockers for the treatment of chronic inflammatory pain.
Neurosci Lett. 2013 Dec 17;557 Pt A:19-26. doi: 10.1016/j.neulet.2013.08.004. Epub 2013 Aug 11.
6
Ion channel targets and treatment efficacy in neuropathic pain.
J Pain. 2006 Jan;7(1 Suppl 1):S38-47. doi: 10.1016/j.jpain.2005.09.008.
7
Recent advances in the modulation of voltage-gated ion channels for the treatment of epilepsy.
Curr Drug Targets CNS Neurol Disord. 2002 Feb;1(1):81-104. doi: 10.2174/1568007023339463.
8
An Update On Proficiency of Voltage-gated Ion Channel Blockers in the Treatment of Inflammation-associated Diseases.
Curr Drug Targets. 2022;23(14):1290-1303. doi: 10.2174/1389450123666220819141827.
9
Axonal voltage-gated ion channels as pharmacological targets for pain.
Eur J Pharmacol. 2013 May 15;708(1-3):105-12. doi: 10.1016/j.ejphar.2013.03.001. Epub 2013 Mar 13.
10
Recent progress in sodium channel modulators for pain.
Bioorg Med Chem Lett. 2014 Aug 15;24(16):3690-9. doi: 10.1016/j.bmcl.2014.06.038. Epub 2014 Jun 21.

引用本文的文献

本文引用的文献

1
Prophylactic gabapentin during head and neck cancer therapy: a systematic review and meta-analysis.
Support Care Cancer. 2023 Mar 17;31(4):221. doi: 10.1007/s00520-023-07683-w.
3
Postoperative pain management in non-traumatic emergency general surgery: WSES-GAIS-SIAARTI-AAST guidelines.
World J Emerg Surg. 2022 Sep 21;17(1):50. doi: 10.1186/s13017-022-00455-7.
4
Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy.
Nat Rev Endocrinol. 2021 Jul;17(7):400-420. doi: 10.1038/s41574-021-00496-z. Epub 2021 May 28.
5
Expert consensus of the Chinese Association for the Study of Pain on ion channel drugs for neuropathic pain.
World J Clin Cases. 2021 Mar 26;9(9):2100-2109. doi: 10.12998/wjcc.v9.i9.2100.
6
Analysis of Adverse Drug Reactions with Carbamazepine and Oxcarbazepine at a Tertiary Care Hospital.
Yonsei Med J. 2020 Oct;61(10):875-879. doi: 10.3349/ymj.2020.61.10.875.
8
Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial.
J Diabetes Metab Disord. 2019 Aug 13;18(2):575-582. doi: 10.1007/s40200-019-00427-w. eCollection 2019 Dec.
9
Ion Channel Pharmacology for Pain Modulation.
Handb Exp Pharmacol. 2019;260:161-186. doi: 10.1007/164_2019_336.
10
Pharmacogenomics in chronic pain therapy: from disease to treatment and challenges for clinical practice.
Pharmacogenomics. 2019 Aug;20(13):971-982. doi: 10.2217/pgs-2019-0066.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验